A study of polymorphism on cognitive decline in elderly breast cancer patients.

Study aiming for individualized pharmacotherapy based on genetic polymorphism for cognitive decline in elderly breast cancer patients. - Study aiming for individualized pharmacotherapy based on genetic polymorphism for cognitive decline in elderly breast cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050415

Enrollment

100

Registered

2023-02-22

Start date

2023-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Persons who participated in the study of 'A multicenter cohort study of the effects of adjuvant treatments on cognitive functioning in older patients with breast cancer (UMIN000049563)'. 2) Persons who obtained written consent for participation in research 3) Age at the time of consent acquisition is over 70 years old 4) Those who have been diagnosed as "histologically primary breast cancer" 5) A person who can completely remove the visually identifiable lesion and does not have distant metastasis 6) Those who are scheduled to carry out the best treatment for breast cancer

Exclusion criteria

Exclusion criteria: 1) Person who has serious organ dysfunction and cannot receive chemotherapy treatment 2) A person who has judged that incorporation into research is inappropriate

Design outcomes

Primary

Measure	Time frame
Onset of cognitive disorders	—

Countries

Japan

Contacts

Public ContactAkimitsu Maeda

Aichi Cancer Center Hospital Department of Pharmacy

m.akimitsu@aichi-cc.jp052-762-6111

Outcome results